Immediate postoperative effects of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy using carboplatin on peritoneal tissue inflammatory and ischemic responses: an explorative porcine study
Open Access
- 22 April 2025
- journal article
- research article
- Published by Walter de Gruyter GmbH in Pleura and Peritoneum
- Vol. 10 (2) , 69-80
Abstract
Objectives: This explorative porcine study investigated the immediate postoperative response of inflammatory protein markers and ischemic metabolites in peritoneal abdominal wall tissue during and after hyperthermic intraperitoneal chemotherapy (HIPEC) assessed by microdialysis. Methods: Eight cancer-free female pigs underwent imitation cytoreductive surgery (CRS) followed by HIPEC (90 min) using a carboplatin dosage of 800 mg/m2. A subperitoneal microdialysis catheter was placed in the abdominal wall to sample inflammatory protein markers and ischemic metabolites. During and after HIPEC, dialysates and blood samples were collected over 8 h. Inflammatory protein expression levels were quantified using Proximity Extension Assay (Olink Target 96 Inflammation panel). In addition, concentrations of ischemic metabolites were quantified using a CMA600 microdialysis analyzer. Results: An immediate response of 27 proteins, including proteins from the TNF family, early inflammatory chemokines, pro- and anti-inflammatory proteins, was found within the first 30 min after HIPEC initiation. This was followed by a modest and relatively constant inflammatory response. Glycerol concentrations tended to decrease during the sampling period, while glucose showed more stable levels. Constant hyperlactatemia exceeding the plasma levels was seen during and after HIPEC, with no significant tissue ischemia as indicated by the lactate/pyruvate ratios. Conclusions: In a porcine model, CRS with HIPEC leads to an immediate and relatively constant increased inflammatory and ischemic peritoneal tissue short-time response. The explorative findings contribute to the debate on the value of HIPEC in combination with CRS and call for future studies to further investigate the inflammatory and metabolic tissue responses.Keywords
Funding Information
- Vissing Fonden (525902 AHO/dhy)
- Knud og Edith Eriksens Mindefond
- Arvid Nilssons Fond
- Frimodt Heineke Fonden
- Familien Hede Nielsens Fond (2022-1480)
- Danish Cancer Society Research Center (A16798)
- Helga og Peter Kornings Fond (DC274023-KMU)
- Læge Agnethe Løvgreens Legat
- Fonden til Lægevidenskabens Fremme (20-L-0292)
- Riisfort Fonden
- Carl og Ellen Hertz’ Legat (7179-2)
- Torben og Alice Frimodts Fond
This publication has 51 references indexed in Scilit:
- Negligible In Vitro Recovery of Macromolecules from Microdialysis Using 100 kDa Probes and Dextran in Perfusion FluidNeurochemical Research, 2024
- The potential role of interleukins and interferons in ovarian cancerCytokine, 2023
- Intraoperative metabolic changes associated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapyLangenbeck's Archives of Surgery, 2023
- Clinical and predictive value of blood lactate levels during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): a comparative analysisUpdates in Surgery, 2020
- Markers of Inflammation2018
- A Review on Microdialysis Calibration Methods: the Theory and Current Related EffortsMolecular Neurobiology, 2016
- IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergyCurrent Opinion in Immunology, 2014
- Cell Response to SurgeryArchives of Surgery, 2006
- Transforming Growth Factor (TGF) Alpha2004
- Leukemia Inhibitory Factor, Interleukin 6, and Other Cytokines Using the GP130 Transducing Receptor: Roles in Inflammation and InjuryStem Cells, 1999